# OnCo record abvd-beacopp (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/abvd-beacopp/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "abvd-beacopp" ;
  schema:name "ABVD, BEACOPP and BrECADD (Hodgkin lymphoma regimens)"@en ;
  schema:alternateName "ABVD"@en, "A+AVD"@en, "AVD"@en, "BV-AVD"@en, "brentuximab vedotin-AVD"@en, "BEACOPP"@en, "escalated BEACOPP"@en, "eBEACOPP"@en, "BrECADD"@en, "N-AVD"@en, "nivolumab-AVD"@en, "Stanford V"@en ;
  schema:description "The chemotherapy recipes that cure most Hodgkin lymphoma: ABVD (four drugs, the long-standing standard), the more intensive German BEACOPP, and newer versions that replace bleomycin with brentuximab vedotin (A+AVD) or add nivolumab (N-AVD)."@en ;
  schema:url <https://onco.cc/terms/abvd-beacopp/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/ABVD> ;
  schema:citation <https://en.wikipedia.org/wiki/ABVD> ;
  onco:related <https://onco.cc/terms/deauville/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/de-escalation/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/bleomycin/> .